Biohit Oyj (BIOBV.HE)

BIOBV.HE on Helsinki Stock Exchange

11:29am EDT
Price Change (% chg)

€0.01 (+0.17%)
Prev Close
Day's High
Day's Low
Avg. Vol
52-wk High
52-wk Low


Chart for BIOBV.HE


Biohit Oyj is a Finland-based company that develops, manufactures and markets diagnostic tests and analysis systems. The Company operates within one business segment, Diagnostics. The Diagnostics business segment offers solutions for the early diagnosis and prevention of gastrointestinal diseases, such as GastroPanel examination... (more)
No analyst recommendations are available for BIOBV.HE.


Beta: 0.87
Market Cap (Mil.): €65.67
Shares Outstanding (Mil.): 11.06
Dividend: 0.72
Yield (%): 12.18


  BIOBV.HE Industry Sector
P/E (TTM): -- 32.42 33.29
EPS (TTM): -0.43 -- --
ROI: -20.09 18.10 17.33
ROE: -20.23 18.81 18.19
Search Stocks

BRIEF-Biohit Oyj to sign an Acetium lozenge distribution agreement

Aug 15 - Biohit Oyj : * Biohit Oyj and Eastar Pharmaceuticals LLC to sign an Acetium lozenge

15 Aug 2014

Earnings vs. Estimates

Analyst Research Reports

Report Title Price
Provider: Reuters Investment Profile
Provider: GlobalData
Provider: GlobalData
Provider: GlobalData
Provider: GlobalData

NYSE and AMEX quotes delayed by at least 20 minutes. NASDAQ delayed by at least 15 minutes. For a complete list of exchanges and delays, please click here.

Search Stocks